drugset / Trial / NCT00159263
Effect of Symbicort on GR Localisation in Asthma
RandomizedCrossoverDouble-blindBasic science
Summary
To investigate a possible interaction between formoterol and budesonide on GR-translocation and to compare the effect of different doses of Symbicort (80/4.5 and 2x80/4.5 mcg) with the effect of budesonide (200 mcg and 800 mcg) on GR translocation, and to investigate the effect of the study drugs on exhaled NO (bronchial and alveolar fraction.
Timeline
- Start
- 2004-11
- Primary completion
- 2006-11
- Completion
- 2006-11
Outcome
Met primary endpoint
registry Placebo vs Budesonide/Formoterol Combination Single; p = 0.04; ANOVA NCT00159263 ↗
registry Placebo vs Budesonide/Formoterol Combination Double; p = 0.01; ANOVA NCT00159263 ↗
registry Placebo vs Budesonide/Formoterol Combination Double; p = 0.04; ANOVA NCT00159263 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 100 ug | Inhaled |
| Subject | Budesonide | Small molecule | 200 ug | Inhaled |
| Subject | Budesonide | Small molecule | 800 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 6 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |